PHOENIX BIOTECH ACQUISITION CORP.

Company

CERO THERAPEUTICS HOLDINGS, INC.

Filed

October 22, 2021

Accession Number

0000902664-21-004578

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →